FDA
approval
· 2025-05-29
FDA Approved: MESALAMINE — Supplemental Application (Lannett Company Inc.)
Summary
FDA approved a supplemental application for Mesalamine (generic) from Lannett Company Inc., for the treatment of ulcerative colitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MESALAMINE (MESALAMINE)